Explore
Validate
Learn66883-1-Ig
antibody from Proteintech Group
Targeting: SLC3A2
4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66883-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- CD98/SLC3A2 antibody
- Antibody type
- Monoclonal
- Description
- CD98/SLC3A2 antibody (Cat. #66883-1-Ig) is a mouse monoclonal antibody that shows reactivity with Human and has been validated for the following applications: FC, IHC, WB,ELISA.
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 2B10F5
- Vial size
- 20ul, 150ul
Submitted references Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer.
Hsa_circ_0050900 affects ferroptosis in intrahepatic cholangiocarcinoma cells by targeting hsa‑miR-605‑3p to regulate SLC3A2.
Identification of the target protein and molecular mechanism of honokiol in anti-inflammatory action.
Matrix stiffness-dependent STEAP3 coordinated with PD-L2 identify tumor responding to sorafenib treatment in hepatocellular carcinoma.
Homosalate boosts the release of tumour-derived extracellular vesicles with protection against anchorage-loss property.
Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9.
Han X, Wang D, Yang L, Wang N, Shen J, Wang J, Zhang L, Chen L, Gao S, Zong WX, Wang Y
Proceedings of the National Academy of Sciences of the United States of America 2024 Mar 26;121(13):e2319429121
Proceedings of the National Academy of Sciences of the United States of America 2024 Mar 26;121(13):e2319429121
Hsa_circ_0050900 affects ferroptosis in intrahepatic cholangiocarcinoma cells by targeting hsa‑miR-605‑3p to regulate SLC3A2.
Shi X, Yang J, Wang M, Xia L, Zhang L, Qiao S
Oncology letters 2024 Jan;27(1):2
Oncology letters 2024 Jan;27(1):2
Identification of the target protein and molecular mechanism of honokiol in anti-inflammatory action.
Cai X, Jiang X, Zhao M, Su K, Tang M, Hong F, Ye N, Zhang R, Li N, Wang L, Xue L, Zhu Z, Chen L, Yang J, Wu W, Ye H
Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 Jan;109:154617
Phytomedicine : international journal of phytotherapy and phytopharmacology 2023 Jan;109:154617
Matrix stiffness-dependent STEAP3 coordinated with PD-L2 identify tumor responding to sorafenib treatment in hepatocellular carcinoma.
Wang S, Chen L, Liu W
Cancer cell international 2022 Oct 13;22(1):318
Cancer cell international 2022 Oct 13;22(1):318
Homosalate boosts the release of tumour-derived extracellular vesicles with protection against anchorage-loss property.
Grisard E, Nevo N, Lescure A, Doll S, Corbé M, Jouve M, Lavieu G, Joliot A, Nery ED, Martin-Jaular L, Théry C
Journal of extracellular vesicles 2022 Jul;11(7):e12242
Journal of extracellular vesicles 2022 Jul;11(7):e12242
Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9.
Mathieu M, Névo N, Jouve M, Valenzuela JI, Maurin M, Verweij FJ, Palmulli R, Lankar D, Dingli F, Loew D, Rubinstein E, Boncompain G, Perez F, Théry C
Nature communications 2021 Jul 19;12(1):4389
Nature communications 2021 Jul 19;12(1):4389
No comments: Submit comment
No validations: Submit validation data